At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of ...
In a quest to provide more relevant translational data, traditional in vivo models join forces with new approach methodologies.
Scale becomes manageable when generative AI is treated as a service with explicit constraints and measurable outcomes. Rely ...
Opioid overdose's respiratory depression can damage oxygen-sensitive brain cells, produce lasting cognitive and emotional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results